474 related articles for article (PubMed ID: 32522677)
1. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
3. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
[TBL] [Abstract][Full Text] [Related]
4. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
5. The COngenital HeARt Disease in adult and Pulmonary Hypertension (COHARD-PH) registry: a descriptive study from single-center hospital registry of adult congenital heart disease and pulmonary hypertension in Indonesia.
Dinarti LK; Hartopo AB; Kusuma AD; Satwiko MG; Hadwiono MR; Pradana AD; Anggrahini DW
BMC Cardiovasc Disord; 2020 Apr; 20(1):163. PubMed ID: 32264836
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
Duffels MG; Engelfriet PM; Berger RM; van Loon RL; Hoendermis E; Vriend JW; van der Velde ET; Bresser P; Mulder BJ
Int J Cardiol; 2007 Aug; 120(2):198-204. PubMed ID: 17182132
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
8. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
Chazova IE; Arkhipova OA; Martynyuk TV
Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
[TBL] [Abstract][Full Text] [Related]
12. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
[TBL] [Abstract][Full Text] [Related]
13. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Yaylalı YT; Yağmur B; Sinan ÜY; Meriç M; Başarıcı İ; Kılıçkıran Avcı B; Şenol H; Nalbantgil S; Küçükoğlu S; Öngen Z
Anatol J Cardiol; 2023 Aug; 27(8):479-485. PubMed ID: 37288853
[TBL] [Abstract][Full Text] [Related]
15. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
[TBL] [Abstract][Full Text] [Related]
16. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
17. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
18. [Screening study of pulmonary arterial hypertension in patients with congenital heart diseases].
Sun YJ; Pang KJ; Zeng WJ; Wang H; He JG
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1091-4. PubMed ID: 22781765
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
[TBL] [Abstract][Full Text] [Related]
20. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
Luna-Lopez R; Segura de la Cal T; Sarnago Cebada F; Martin de Miguel I; Hinojosa W; Cruz-Utrilla A; Velazquez MT; Delgado JF; Mendoza A; Arribas Ynsaurriaga F; Escribano-Subías P
Heart; 2024 Feb; 110(5):346-352. PubMed ID: 37903556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
